Who we are
We are the first startup from the Okinawa Institute of Science and Technology
Graduate University (OIST) established on June 25, 2014. The company has
grown from advanced structural imaging technology developed by Professor
Ulf Skoglund of the OIST Structural Cellular Biology Unit.
Based in Onna-son, Okinawa, headed by CEO Akira Kamei, we provide contracted research services worldwide.
What we do
We provide service of macromolecules imaging including proteins in various
states at the single molecule-level by combining conventional electron
tomography and a specifically designed 3D reconstruction program known
as COMET. The current resolution of a 3D image produced by this technique
is approximately 1.5 nanometers and the resolution is steadily improving.
For decades, pharmaceutical companies have studied the structure of proteins
on the surface of human cells to develop drugs that latch onto the proteins
and block the entry of a virus or bacteria. The new technology also allows
visualization of protein complexes and their dynamics, serving as an alternative
solution to the study of biological samples that are difficult or impossible
The ultimate goal of imaging protein structures is to provide data for new drug design. By utilizing data obtained by the new technology at various stages of the drug development, pharmaceutical companies will be able to analyze drug candidates efficiently and effectively.
More about our services here
More about Protein Tomography here
Name: Okinawa Protein Tomography Ltd. (OKPT)
Date of Establishment: June 25, 2014
Head Office: Uruma-shi, Okinawa
Branch: Onna-son, Okinawa
Capital: 80 million JPY
CEO: Akira Kamei
Director: Nobuo Fukuda (BSC)
Director: Kazuhiro Hara (BSC)
Technical Consultant: Ulf Skoglund (OIST)
Scope of Business: Contract research service using imaging and analyzing technology for macromolecules
Detailed company info here